Julio C. Cuggino, Luis I. Tártara, Luis M. Gugliotta, Santiago D. Palma & Cecilia I. Alvarez Igarzabal. (2021) Mucoadhesive and responsive nanogels as carriers for sustainable delivery of timolol for glaucoma therapy. Materials Science and Engineering: C 118, pages 111383.
Crossref
N.J. Vignesh, P. Shenbaga Velu & Navasingh Rajesh Jesudoss Hynes. 2021. Nanomedicine Manufacturing and Applications. Nanomedicine Manufacturing and Applications
209
220
.
Liwen Wang, Shan Luo, Hongyan Xu, Xiaoxiao Wu, Pengyan Hao, Yagang Zhang, Wenjuan Huang & Xingjie Zan. (2020)
Evaluation of His
6
-Metal Assemblies as a Drug Delivery Vehicle in the Treatment of Anterior Segment Disease Using a Corneal Inflammation Model
. ACS Biomaterials Science & Engineering 6:7, pages 4012-4023.
Crossref
Abhishek K. Sah, Nagendra Bhuwane, Ishwari Choudhary, Shweta Ramkar & Preeti K. Suresh. 2020. Nanoformulations in Human Health. Nanoformulations in Human Health
207
226
.
Manu Sharma, Ankita Deohra, Kakarla Raghava Reddy & Veera Sadhu. 2019. Nanotechnology. Nanotechnology
93
114
.
Julieta C. Imperiale, Gabriela B. Acosta & Alejandro Sosnik. (2018) Polymer-based carriers for ophthalmic drug delivery. Journal of Controlled Release 285, pages 106-141.
Crossref
Rinda Bachu, Pallabitha Chowdhury, Zahraa Al-Saedi, Pradeep Karla & Sai Boddu. (2018) Ocular Drug Delivery Barriers—Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases. Pharmaceutics 10:1, pages 28.
Crossref
Dileep R. Janagam, Linfeng Wu & Tao L. Lowe. (2017) Nanoparticles for drug delivery to the anterior segment of the eye. Advanced Drug Delivery Reviews 122, pages 31-64.
Crossref
Tianyang Zhou, Ling Zhu, Huiyun Xia, Jijun He, Susu Liu, Siyu He, Liya Wang & Junjie Zhang. (2017) Micelle carriers based on macrogol 15 hydroxystearate for ocular delivery of terbinafine hydrochloride: In vitro characterization and in vivo permeation. European Journal of Pharmaceutical Sciences 109, pages 288-296.
Crossref
Ameeduzzafar Zafar, Javed Ahmad, Richard T. Addo & Sohail Akhter. 2016. Ocular Drug Delivery: Advances, Challenges and Applications. Ocular Drug Delivery: Advances, Challenges and Applications
131
163
.
Ameeduzzafar Zafar, Javed Ahmad, Sohail Akhter & Richard T. Addo. 2016. Ocular Drug Delivery: Advances, Challenges and Applications. Ocular Drug Delivery: Advances, Challenges and Applications
75
99
.
Rutika Godse, Kavita Singh, Agnivesh Shrivastava & Ujwala Shinde. 2016. Nano-Biomaterials For Ophthalmic Drug Delivery. Nano-Biomaterials For Ophthalmic Drug Delivery
351
387
.
Harmeet Kaur & Jasbir Singh. 2015. Encyclopedia of Biomedical Polymers and Polymeric Biomaterials. Encyclopedia of Biomedical Polymers and Polymeric Biomaterials
5858
5880
.
Josep Sanchís, Marinella Farré & Damià Barceló. 2015. Nanomaterials in the Environment. Nanomaterials in the Environment
129
157
.
S. Reimondez-Troitiño, N. Csaba, M.J. Alonso & M. de la Fuente. (2015) Nanotherapies for the treatment of ocular diseases. European Journal of Pharmaceutics and Biopharmaceutics 95, pages 279-293.
Crossref
I.M. Carvalho, C.S. Marques, R.S. Oliveira, P.B. Coelho, P.C. Costa & D.C. Ferreira. (2015) Sustained drug release by contact lenses for glaucoma treatment—A review. Journal of Controlled Release 202, pages 76-82.
Crossref
Patricia I. Dolez. 2015. Nanoengineering. Nanoengineering
607
635
.
Patricia I. Dolez & Maximilien Debia. 2015. Nanoengineering. Nanoengineering
427
484
.
José AriasCornelia Vasile, Ana Oprea, Manuela Nistor & Anca-Maria Cojocariu. 2014. Nanotechnology and Drug Delivery, Volume One. Nanotechnology and Drug Delivery, Volume One
28
80
.
Umang Shah, Garima Joshi & Krutika Sawant. (2014) Improvement in antihypertensive and antianginal effects of felodipine by enhanced absorption from PLGA nanoparticles optimized by factorial design. Materials Science and Engineering: C 35, pages 153-163.
Crossref
Farhan Ahmad, Sohail Akhter, Mohammad Ahmad, Farshad Ramazani, Mohammad Samim, Musarrat Warsi, Mohammad Anwar & Ziyaur Rahman. 2013. Chitin and Chitosan Derivatives. Chitin and Chitosan Derivatives
317
336
.
Rajesh Katara & Dipak K. Majumdar. (2013) Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery. Colloids and Surfaces B: Biointerfaces 103, pages 455-462.
Crossref
Kris Hermans, Dave Van den Plas, Arnout Everaert, Wim Weyenberg & Annick Ludwig. (2012) Full factorial design, physicochemical characterisation and biological assessment of cyclosporine A loaded cationic nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics 82:1, pages 27-35.
Crossref
Himanshu Gupta & Mohammed Aqil. (2012) Contact lenses in ocular therapeutics. Drug Discovery Today 17:9-10, pages 522-527.
Crossref
Burçin Yavuz, Sibel Bozdağ Pehlivan & Nurşen Ünlü. (2012) An Overview on Dry Eye Treatment: Approaches for Cyclosporin A Delivery. The Scientific World Journal 2012, pages 1-11.
Crossref
Jaime Salazar, Oliver Heinzerling, Rainer H. Müller & Jan P. Möschwitzer. (2011) Process optimization of a novel production method for nanosuspensions using design of experiments (DoE). International Journal of Pharmaceutics 420:2, pages 395-403.
Crossref
Zhe Liu, Twan Lammers, Josef Ehling, Stanley Fokong, Jörg Bornemann, Fabian Kiessling & Jessica Gätjens. (2011) Iron oxide nanoparticle-containing microbubble composites as contrast agents for MR and ultrasound dual-modality imaging. Biomaterials 32:26, pages 6155-6163.
Crossref
Koichi Baba, Yuji Tanaka, Akira Kubota, Hitoshi Kasai, Shunji Yokokura, Hachiro Nakanishi & Kohji Nishida. (2011) A method for enhancing the ocular penetration of eye drops using nanoparticles of hydrolyzable dye. Journal of Controlled Release 153:3, pages 278-287.
Crossref
Hamdy Abdelkader, Sayed Ismail, Amal Kamal & Raid G. Alany. (2011) Design and Evaluation of Controlled-Release Niosomes and Discomes for Naltrexone Hydrochloride Ocular Delivery. Journal of Pharmaceutical Sciences 100:5, pages 1833-1846.
Crossref
Pilar Calvo, María J Alonso, José L Vila-Jato & Joseph R Robinson. (1996) Improved Ocular Bioavailability of Indomethacin by Novel Ocular Drug Carriers. Journal of Pharmacy and Pharmacology 48:11, pages 1147-1152.
Crossref
Robert A Yokel & Robert C MacPhail. (2011) Engineered nanomaterials: exposures, hazards, and risk prevention. Journal of Occupational Medicine and Toxicology 6:1, pages 7.
Crossref
Yolanda Diebold & Margarita Calonge. (2010) Applications of nanoparticles in ophthalmology. Progress in Retinal and Eye Research 29:6, pages 596-609.
Crossref
Swarnali Das, Preeti K. Suresh & Rohitas Desmukh. (2010) Design of Eudragit RL 100 nanoparticles by nanoprecipitation method for ocular drug delivery. Nanomedicine: Nanotechnology, Biology and Medicine 6:2, pages 318-323.
Crossref
Swarnali Das & Preeti K. Suresh. (2010) Drug delivery to eye: Special reference to nanoparticle.. International Journal of Drug Delivery 2:1, pages 12-21.
Crossref
Shayne Cox GadSophia G. Antimisiaris, Paraskevi Kallinteri & Dimitrios G. Fatouros. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
María José Alonso & Alejandro Sánchez. (2003) The potential of chitosan in ocular drug delivery. Journal of Pharmacy and Pharmacology 55:11, pages 1451-1463.
Crossref
M. Niu, K. Shi, Y. Sun, J. Wang & F. Cui. (2008) Preparation of CyA-loaded solid lipid nanoparticles and application on ocular preparations. Journal of Drug Delivery Science and Technology 18:4, pages 293-297.
Crossref
Denise K. Chun, Aron Shapiro & Mark B. Abelson. 2008. Albert & Jakobiec's Principles & Practice of Ophthalmology. Albert & Jakobiec's Principles & Practice of Ophthalmology
179
192
.
Samuel R. Pygall, Joanne Whetstone, Peter Timmins & Colin D. Melia. (2007) Pharmaceutical applications of confocal laser scanning microscopy: The physical characterisation of pharmaceutical systems. Advanced Drug Delivery Reviews 59:14, pages 1434-1452.
Crossref
Basavaraj K. Nanjawade, F.V. Manvi & A.S. Manjappa. (2007) RETRACTED: In situ-forming hydrogels for sustained ophthalmic drug delivery. Journal of Controlled Release 122:2, pages 119-134.
Crossref
C.C. Li & A. Chauhan. (2007) Ocular transport model for ophthalmic delivery of timolol through p-HEMA contact lenses. Journal of Drug Delivery Science and Technology 17:1, pages 69-79.
Crossref
E. Vega, M.A. Egea, O. Valls, M. Espina & M.L. García. (2006) Flurbiprofen Loaded Biodegradable Nanoparticles for Ophtalmic Administration. Journal of Pharmaceutical Sciences 95:11, pages 2393-2405.
Crossref
Catarina Pinto Reis, Ronald J. Neufeld, António J. Ribeiro & Francisco Veiga. (2006) Nanoencapsulation II. Biomedical applications and current status of peptide and protein nanoparticulate delivery systems. Nanomedicine: Nanotechnology, Biology and Medicine 2:2, pages 53-65.
Crossref
Chi-Chung Li & Anuj Chauhan. (2006) Modeling Ophthalmic Drug Delivery by Soaked Contact Lenses. Industrial & Engineering Chemistry Research 45:10, pages 3718-3734.
Crossref
Aniruddha Amrite & Uday Kompella. 2006. Nanoparticle Technology for Drug Delivery. Nanoparticle Technology for Drug Delivery.
Kathleen Dillen, Wim Weyenberg, Jo Vandervoort & Annick Ludwig. (2004) The influence of the use of viscosifying agents as dispersion media on the drug release properties from PLGA nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics 58:3, pages 539-549.
Crossref
R Alvarez-Román, A Naik, Y.N Kalia, H Fessi & R.H Guy. (2004) Visualization of skin penetration using confocal laser scanning microscopy. European Journal of Pharmaceutics and Biopharmaceutics 58:2, pages 301-316.
Crossref
Kathleen Dillen, Jo Vandervoort, Guy Van den Mooter, Loes Verheyden & Annick Ludwig. (2004) Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles. International Journal of Pharmaceutics 275:1-2, pages 171-187.
Crossref
J Vandervoort & A Ludwig. (2004) Preparation and evaluation of drug-loaded gelatin nanoparticles for topical ophthalmic use. European Journal of Pharmaceutics and Biopharmaceutics 57:2, pages 251-261.
Crossref
Indu P. Kaur, Alka Garg, Anil K. Singla & Deepika Aggarwal. (2004) Vesicular systems in ocular drug delivery: an overview. International Journal of Pharmaceutics 269:1, pages 1-14.
Crossref
E Fattal, D Labarre & C Vauthier. 2003. Tissue Engineering And Novel Delivery Systems. Tissue Engineering And Novel Delivery Systems.
F Lallemand, O Felt-Baeyens, K Besseghir, F Behar-Cohen & R Gurny. (2003) Cyclosporine A delivery to the eye: A pharmaceutical challenge. European Journal of Pharmaceutics and Biopharmaceutics 56:3, pages 307-318.
Crossref
Christine Vauthier, Catherine Dubernet, Elias Fattal, Huguette Pinto-Alphandary & Patrick Couvreur. (2003) Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications. Advanced Drug Delivery Reviews 55:4, pages 519-548.
Crossref
Gangadhar Sunkara & Uday Kompella. 2003. Ophthalmic Drug Delivery Systems, Second Edition. Ophthalmic Drug Delivery Systems, Second Edition
13
58
.
Murali Kothuri, Swathi Pinnamaneni, Nandita Das & Sudip Das. 2003. Ophthalmic Drug Delivery Systems, Second Edition. Ophthalmic Drug Delivery Systems, Second Edition
437
466
.
J Vandervoort & A Ludwig. (2002) Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study. International Journal of Pharmaceutics 238:1-2, pages 77-92.
Crossref
G Barratt, G Couarraze, P Couvreur, C Dubernet, E Fattal, R Gref, D Labarre, P Legrand, G Ponchel & C Vauthier. 2001. Polymeric Biomaterials, Revised and Expanded. Polymeric Biomaterials, Revised and Expanded.
Massimo Fresta, Giacomo Fontana, Claudio Bucolo, Gennara Cavallaro, Gaetano Giammona & Giovanni Puglisi. (2001) Ocular Tolerability and In Vivo Bioavailability of Poly(ethylene glycol) (PEG)‐Coated Polyethyl‐2‐Cyanoacrylate Nanosphere‐Encapsulated Acyclovir. Journal of Pharmaceutical Sciences 90:3, pages 288-297.
Crossref
Chrystèle Le Bourlais, Liliane Acar, Hosein Zia, Pierre A. Sado, Thomas Needham & Roger Leverge. (1998) Ophthalmic drug delivery systems—Recent advances. Progress in Retinal and Eye Research 17:1, pages 33-58.
Crossref
Nimit Worakul & Joseph R. Robinson. (1997) Ocular pharmacokinetics/pharmacodynamics. European Journal of Pharmaceutics and Biopharmaceutics 44:1, pages 71-83.
Crossref
Pilar Calvo, José L. Vila-Jato & María J. Alonso. (1996) Comparative in vitro Evaluation of Several Colloidal Systems, Nanoparticles, Nanocapsules, and Nanoemulsions, as Ocular Drug Carriers. Journal of Pharmaceutical Sciences 85:5, pages 530-536.
Crossref
Andreas Zimmer & Jörg Kreuter. (1995) Microspheres and nanoparticles used in ocular delivery systems. Advanced Drug Delivery Reviews 16:1, pages 61-73.
Crossref
Annette Katharina Zimmer, Horst Zerbe & Jörg Kreuter. (1994) Evaluation of pilocarpine-loaded albumin particles as drug delivery systems for controlled delivery in the eye I. In vitro and in vivo characterisation. Journal of Controlled Release 32:1, pages 57-70.
Crossref
K. Langer, E. Seegmüller, A. Zimmer & J. Kreuter. (1994) Characterisation of polybutylcyanoarylate nanoparticles: I. Quantification of PCBA polymer and dextrans. International Journal of Pharmaceutics 110:1, pages 21-27.
Crossref
. (2008) Bibliography on confocal microscopy and its applications. Scanning 16:1, pages 33-56.
Crossref
CANDIDA LOSA, MARIA J. ALONSO, JOSÉ L. VILA, FRANCISCO ORALLO, JESUS MARTINEZ, JOSÉ A. SAAVEDRA & JOSÉ C. PASTOR. (1992) Reduction of Cardiovascular Side Effects Associated with Ocular Administration of Metipranolol by Inclusion in Polymeric Nanocapsules. Journal of Ocular Pharmacology and Therapeutics 8:3, pages 191-198.
Crossref